Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 7 filers reported holding Astellas Pharma Inc in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $17,000 | 0.0% | 1,086 | +0.2% | 0.01% | +225.0% |
Q1 2022 | $17,000 | +13.3% | 1,084 | +17.3% | 0.00% | +33.3% |
Q4 2021 | $15,000 | 0.0% | 924 | -1.1% | 0.00% | 0.0% |
Q3 2021 | $15,000 | -6.2% | 934 | +0.1% | 0.00% | -25.0% |
Q2 2021 | $16,000 | -11.1% | 933 | -20.3% | 0.00% | 0.0% |
Q1 2021 | $18,000 | -41.9% | 1,170 | -41.3% | 0.00% | -33.3% |
Q4 2020 | $31,000 | -3.1% | 1,994 | -8.2% | 0.01% | -14.3% |
Q3 2020 | $32,000 | -15.8% | 2,171 | -4.6% | 0.01% | -12.5% |
Q2 2020 | $38,000 | +15.2% | 2,276 | +5.5% | 0.01% | -11.1% |
Q1 2020 | $33,000 | +50.0% | 2,157 | +68.3% | 0.01% | +80.0% |
Q4 2019 | $22,000 | +4.8% | 1,282 | -13.8% | 0.01% | +25.0% |
Q3 2019 | $21,000 | +133.3% | 1,487 | +152.9% | 0.00% | +100.0% |
Q2 2019 | $9,000 | -55.0% | 588 | -56.9% | 0.00% | -50.0% |
Q1 2019 | $20,000 | +122.2% | 1,365 | +84.2% | 0.00% | +100.0% |
Q4 2018 | $9,000 | -35.7% | 741 | -13.2% | 0.00% | -33.3% |
Q3 2018 | $14,000 | +16.7% | 854 | +4.1% | 0.00% | 0.0% |
Q2 2018 | $12,000 | 0.0% | 820 | +4.3% | 0.00% | 0.0% |
Q1 2018 | $12,000 | +71.4% | 786 | +258.9% | 0.00% | +50.0% |
Q4 2017 | $7,000 | – | 219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
MAI Capital Management | 19,087 | $264,362 | 0.00% |
SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
Operose Advisors LLC | 90 | $1,247 | 0.00% |
Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |